| 1 |
Hanai T. Further quantitative in silico analysis of SARS-CoV-2 S-RBD Omicron BA.4, BA.5, BA.2.75, BQ.1, and BQ.1.1 transmissibility. Talanta 2023;254:124127. [PMID: 36462284 DOI: 10.1016/j.talanta.2022.124127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Spiegel M, Ciardullo G, Marino T, Russo N. Computational investigation on the antioxidant activities and on the Mpro SARS-CoV-2 non-covalent inhibition of isorhamnetin. Front Chem 2023;11. [DOI: 10.3389/fchem.2023.1122880] [Reference Citation Analysis]
|
| 3 |
Wang F, Chen L, Chen H, Yan Z, Liu Y. Discovery of the key active compounds in Citri Reticulatae Pericarpium (Citrus reticulata "Chachi") and their therapeutic potential for the treatment of COVID-19 based on comparative metabolomics and network pharmacology. Front Pharmacol 2022;13:1048926. [PMID: 36506534 DOI: 10.3389/fphar.2022.1048926] [Reference Citation Analysis]
|
| 4 |
Bajrai LH, Faizo AA, Alkhaldy AA, Dwivedi VD, Azhar EI. Repositioning of anti-dengue compounds against SARS-CoV-2 as viral polyprotein processing inhibitor. PLoS One 2022;17:e0277328. [PMID: 36383621 DOI: 10.1371/journal.pone.0277328] [Reference Citation Analysis]
|
| 5 |
Lin Y, Zhang Y, Wang D, Yang B, Shen Y. Computer especially AI-Assisted Drug Virtual Screening and Design in Traditional Chinese Medicine. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154481] [Reference Citation Analysis]
|
| 6 |
Moin A, Huwaimel B, Alobaida A, Break MKB, Iqbal D, Unissa R, Jamal QMS, Hussain T, Sharma DC, Rizvi SMD. Dithymoquinone Analogues as Potential Candidate(s) for Neurological Manifestation Associated with COVID-19: A Therapeutic Strategy for Neuro-COVID. Life (Basel) 2022;12:1076. [PMID: 35888166 DOI: 10.3390/life12071076] [Reference Citation Analysis]
|
| 7 |
Guillaume YC, André C. ACE2 and SARS-CoV-2-Main Protease Capillary Columns for Affinity Chromatography: Testimony of the Binding of Dexamethasone and its Carbon Nanotube Nanovector. Chromatographia. [DOI: 10.1007/s10337-022-04181-9] [Reference Citation Analysis]
|
| 8 |
Lam T, Nguyen D, Mai TT, Tran T, Le M, Huynh PNH, Nguyen D, Tran V, Trinh DT, Truong P, Vo CT, Thai K. Exploration of chalcones as 3-chymotrypsin-like protease (3CLpro) inhibitors of SARS-CoV-2 using computational approaches. Struct Chem. [DOI: 10.1007/s11224-022-02000-3] [Reference Citation Analysis]
|
| 9 |
Zhu Y, Scholle F, Kisthardt SC, Xie D. Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E. Virology 2022;571:21-33. [DOI: 10.1016/j.virol.2022.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Wansri R, Lin ACK, Pengon J, Kamchonwongpaisan S, Srimongkolpithak N, Rattanajak R, Wilasluck P, Deetanya P, Wangkanont K, Hengphasatporn K, Shigeta Y, Liangsakul J, Suroengrit A, Boonyasuppayakorn S, Chuanasa T, De-Eknamkul W, Hannongbua S, Rungrotmongkol T, Chamni S. Semi-Synthesis of N-Aryl Amide Analogs of Piperine from Piper nigrum and Evaluation of Their Antitrypanosomal, Antimalarial, and Anti-SARS-CoV-2 Main Protease Activities. Molecules 2022;27:2841. [PMID: 35566194 DOI: 10.3390/molecules27092841] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 11 |
Mevada V, Patel R, Dudhagara P, Gandhi H, Beladiya U, Vaghamshi N, Godhaniya M, Ghelani A. Variant Analysis and Strategic Clustering to Sub-Lineage of Double Mutant Strain B.1.617 of SARS-CoV-2. COVID 2022;2:513-531. [DOI: 10.3390/covid2050038] [Reference Citation Analysis]
|
| 12 |
Hengphasatporn K, Wilasluck P, Deetanya P, Wangkanont K, Chavasiri W, Visitchanakun P, Leelahavanichkul A, Paunrat W, Boonyasuppayakorn S, Rungrotmongkol T, Hannongbua S, Shigeta Y. Halogenated Baicalein as a Promising Antiviral Agent toward SARS-CoV-2 Main Protease. J Chem Inf Model 2022. [PMID: 35245424 DOI: 10.1021/acs.jcim.1c01304] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 13 |
Suleimen YM, Jose RA, Suleimen RN, Arenz C, Ishmuratova MY, Toppet S, Dehaen W, Alsfouk BA, Elkaeed EB, Eissa IH, Metwaly AM. Jusanin, a New Flavonoid from Artemisia commutata with an In Silico Inhibitory Potential against the SARS-CoV-2 Main Protease. Molecules 2022;27. [PMID: 35268738 DOI: 10.3390/molecules27051636] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 14 |
de Loera D. The role of traditional medicine in the fight against SARS-CoV-2. Biomedical Innovations to Combat COVID-19 2022. [DOI: 10.1016/b978-0-323-90248-9.00019-x] [Reference Citation Analysis]
|
| 15 |
Alanazi KM, Farah MA, Hor YY. Multi-Targeted Approaches and Drug Repurposing Reveal Possible SARS-CoV-2 Inhibitors. Vaccines (Basel) 2021;10:24. [PMID: 35062685 DOI: 10.3390/vaccines10010024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Liu CH, Lu CH, Lin LT. Pandemic Strategies with Computational and Structural Biology against COVID-19: A Retrospective. Comput Struct Biotechnol J 2021. [PMID: 34900126 DOI: 10.1016/j.csbj.2021.11.040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 17 |
Rubio-Martínez J, Jiménez-Alesanco A, Ceballos-Laita L, Ortega-Alarcón D, Vega S, Calvo C, Benítez C, Abian O, Velázquez-Campoy A, Thomson TM, Granadino-Roldán JM, Gómez-Gutiérrez P, Pérez JJ. Discovery of Diverse Natural Products as Inhibitors of SARS-CoV-2 M(pro) Protease through Virtual Screening. J Chem Inf Model 2021;61:6094-106. [PMID: 34806382 DOI: 10.1021/acs.jcim.1c00951] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Sancineto L, Ostacolo C, Ortega-Alarcon D, Jimenez-Alesanco A, Ceballos-Laita L, Vega S, Abian O, Velazquez-Campoy A, Moretti S, Dabrowska A, Botwina P, Synowiec A, Kula-Pacurar A, Pyrc K, Iraci N, Santi C. l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in Cells. Molecules 2021;26:6062. [PMID: 34641606 DOI: 10.3390/molecules26196062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 19 |
Khedri M, Maleki R, Dahri M, Sadeghi MM, Rezvantalab S, Santos HA, Shahbazi MA. Engineering of 2D nanomaterials to trap and kill SARS-CoV-2: a new insight from multi-microsecond atomistic simulations. Drug Deliv Transl Res 2021. [PMID: 34476766 DOI: 10.1007/s13346-021-01054-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Rizzuti B, Ceballos-Laita L, Ortega-Alarcon D, Jimenez-Alesanco A, Vega S, Grande F, Conforti F, Abian O, Velazquez-Campoy A. Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds. Pharmaceuticals (Basel) 2021;14:892. [PMID: 34577592 DOI: 10.3390/ph14090892] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 21 |
Arora G, Joshi J, Mandal RS, Shrivastava N, Virmani R, Sethi T. Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19. Pathogens 2021;10:1048. [PMID: 34451513 DOI: 10.3390/pathogens10081048] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 22 |
Arora G, Joshi J, Mandal RS, Shrivastava N, Virmani R, Sethi T. Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19. Pathogens 2021;10:1048. [PMID: 34451513 DOI: 10.3390/pathogens10081048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 23 |
Umar AK. Flavonoid compounds of buah merah (Pandanus conoideus Lamk) as a potent SARS-CoV-2 main protease inhibitor: in silico approach. Futur J Pharm Sci 2021;7:158. [PMID: 34395638 DOI: 10.1186/s43094-021-00309-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 24 |
Jiménez-Avalos G, Vargas-Ruiz AP, Delgado-Pease NE, Olivos-Ramirez GE, Sheen P, Fernández-Díaz M, Quiliano M, Zimic M; COVID-19 Working Group in Perú. Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 M(PRO). Sci Rep 2021;11:15452. [PMID: 34326429 DOI: 10.1038/s41598-021-94951-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 25 |
Leal CM, Leitão SG, Sausset R, Mendonça SC, Nascimento PHA, de Araujo R Cheohen CF, Esteves MEA, Leal da Silva M, Gondim TS, Monteiro MES, Tucci AR, Fintelman-Rodrigues N, Siqueira MM, Miranda MD, Costa FN, Simas RC, Leitão GG. Flavonoids from Siparuna cristata as Potential Inhibitors of SARS-CoV-2 Replication. Rev Bras Farmacogn 2021;:1-9. [PMID: 34305198 DOI: 10.1007/s43450-021-00162-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 26 |
Deetanya P, Hengphasatporn K, Wilasluck P, Shigeta Y, Rungrotmongkol T, Wangkanont K. Interaction of 8-anilinonaphthalene-1-sulfonate with SARS-CoV-2 main protease and its application as a fluorescent probe for inhibitor identification. Comput Struct Biotechnol J 2021;19:3364-71. [PMID: 34109016 DOI: 10.1016/j.csbj.2021.05.053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 27 |
Alzaabi MM, Hamdy R, Ashmawy NS, Hamoda AM, Alkhayat F, Khademi NN, Al Joud SMA, El-Keblawy AA, Soliman SSM. Flavonoids are promising safe therapy against COVID-19. Phytochem Rev 2021;:1-22. [PMID: 34054380 DOI: 10.1007/s11101-021-09759-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 28 |
Santana FPR, Thevenard F, Gomes KS, Taguchi L, Câmara NOS, Stilhano RS, Ureshino RP, Prado CM, Lago JHG. New perspectives on natural flavonoids on COVID-19-induced lung injuries. Phytother Res 2021. [PMID: 33928690 DOI: 10.1002/ptr.7131] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 29 |
Agrawal PK, Agrawal C, Blunden G. Rutin: A Potential Antiviral for Repurposing as a SARS-CoV-2 Main Protease (M pro ) Inhibitor. Natural Product Communications 2021;16:1934578X2199172. [DOI: 10.1177/1934578x21991723] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 30 |
Rizzuti B, Grande F, Conforti F, Jimenez-Alesanco A, Ceballos-Laita L, Ortega-Alarcon D, Vega S, Reyburn HT, Abian O, Velazquez-Campoy A. Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs. Biomedicines 2021;9:375. [PMID: 33918402 DOI: 10.3390/biomedicines9040375] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 31 |
Gour A, Manhas D, Bag S, Gorain B, Nandi U. Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2. Phytother Res 2021;35:4258-83. [PMID: 33786876 DOI: 10.1002/ptr.7092] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 32 |
Sahoo BM, Ravi Kumar BVV, Sruti J, Mahapatra MK, Banik BK, Borah P. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection. Front Mol Biosci 2021;8:628144. [PMID: 33718434 DOI: 10.3389/fmolb.2021.628144] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 33 |
Gomez CR, Espinoza I, Faruque FS, Hasan MM, Rahman KM, Walker LA, Muhammad I. Therapeutic Intervention of COVID-19 by Natural Products: A Population-Specific Survey Directed Approach. Molecules 2021;26:1191. [PMID: 33672163 DOI: 10.3390/molecules26041191] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 34 |
Chaturvedi S, Chaudhary V, Klauss T, Barthélémy P, Mishra AK. Harnessing the Capability of CADD Methods in the Prediction of Anti-COVID Drug Likeliness. Advances in Medical Diagnosis, Treatment, and Care 2021. [DOI: 10.4018/978-1-7998-0307-2.ch011] [Reference Citation Analysis]
|
